Choi Jong Yun, Choi Young Jae, Jung Sung-No, Seo Bommie F
Department of Plastic and Reconstructive Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Plastic and Reconstructive Surgery, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.
Gland Surg. 2023 Aug 30;12(8):1131-1136. doi: 10.21037/gs-23-9. Epub 2023 Aug 11.
Breast augmentation is one of the most commonly performed aesthetic procedures in the world. Aquafilling filler, since its introduction in 2005 has been used for breast or buttock augmentation in several countries. Aquafilling filler is composed of 2% polyacrylamide with 98% sodium chloride 0.9% solution, and is known to have a similar composition with polyacrylamide hydrogel (PAAG) filler, which is also related to a variety of complications. Although many studies have warned against the complications of aquafilling filler, it is still being used for aesthetic purposes.
In this case report, we share our experience of a 36-year-old female patient complaining of smaller left breast and bulging mass in her left upper abdomen. She had a history of transumbilical breast augmentation (TUBA) 11 years prior, which she had had removed via the transumbilical incision 6 years ago. To compensate for the removal of implants, the patient had received large volumes of aquafilling filler injection 2 years after implant removal. Surprisingly, we found out that the filler in the left breast had displaced to the abdominal area.
Accidently displacement may occur, especially in patients who have had previous procedures breaching the inframammary fold including TUBA. Therefore, it is required to observe carefully for those patients who have received breast augmentation or the breast filler injections.
隆胸是世界上最常见的美容手术之一。自2005年引入以来，水填充填充物已在多个国家用于隆胸或丰臀。水填充填充物由2%的聚丙烯酰胺和98%的0.9%氯化钠溶液组成，已知其成分与聚丙烯酰胺水凝胶（PAAG）填充物相似，而PAAG填充物也与多种并发症有关。尽管许多研究已警告过水填充填充物的并发症，但它仍被用于美容目的。
在本病例报告中，我们分享了一位36岁女性患者的经历，该患者抱怨左乳房较小且左上腹有肿块。她11年前有过经脐隆胸（TUBA）病史，6年前通过经脐切口将植入物取出。为了弥补植入物的取出，患者在取出植入物2年后接受了大量水填充填充物注射。令人惊讶的是，我们发现左乳房中的填充物已移位至腹部区域。
意外移位可能会发生，尤其是在那些之前进行过包括TUBA在内的突破乳房下皱襞手术的患者中。因此，对于接受过隆胸或乳房填充物注射的患者需要仔细观察。
